Cancer-related inflammation
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
The mediators and cellular effectors of inflammation are important constituents of the local environment of tumours. In some types of cancer, inflammatory conditions are present before a malignant change occurs. Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumours. Regardless of its origin, 'smouldering' inflammation in the tumour microenvironment has many tumour-promoting effects. It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents. The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many of these processes also occur in cancer as most of them are inflammation-related, including hypoxia-induced neovascularization, endothelial dysfunction, permeability of the microvasculature and the upregulation of adhesion molecules to facilitate the recruitment of cells30,31.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, cytokine production can be triggered by oncogenic transformation, metabolic alteration, cell death, hypoxia, and the use of anti-cancer drugs (10).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides promoting cell proliferation, the action of cytokines in promoting cancer development includes antagonizing anti-tumor immune response, recruiting tumor-supportive stromal cells and immune-suppressive cells, inducing angiogenesis and metastasis, and altering the responses to therapeutic agents (10, 15)”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Excessive or dysregulated inflammation is a major driver of tissue damage and the pathogenesis of numerous diseases, including stroke, Parkinson’s disease, atherosclerosis, and cancer [9,30,31,32,33].”
From Picroside II as a Potential Anti-Inflammatory Agent (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, rather than the dogma that oncogenesis is intrinsically triggered in pre-neoplastic cells, environmental factors, such as infection, stress, obesity, aging and smoking, each of which can induce chronic inflammation, could be a major cause of oncogenesis (4, 6, 9, 233).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [6]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · cited 1×
“jpg" NDATA ITEM> ]> Links between cancer and inflammation were first made in the nineteenth century, on the basis of observations that tumours often arose at sites of chronic inflammation and that inflammatory cells were present in biopsied samples from tumour”
Self-citationMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“TAMs and related cell types in mouse and human tumours generally have an M2 phenotype, which is oriented towards promoting tumour growth, remodelling tissues, promoting angiogenesis and suppressing adaptive immunity&hairsp”
Self-citationInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“This type of response might also contribute to successful chemotherapy or radiotherapy, according to recent data obtained by Lionel Apetoh and colleague”
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“Cancer-related inflammation and adaptive immunity There is strong evidence from genetic studies of mouse models that cells of the adaptive immune system carry out surveillance and can eliminate nascent tumours (a process called immuno-editing”
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790 · cited 1×
“This transcription factor is constitutively activated both in tumour cells and in immune cells, and is involved in oncogenesis and inhibition of apoptosi”
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 1×
“TAMs have been described as “obligate partners for tumour-cell migration, invasion and metastasis&rdquo”
Cited by
Items 601–700 of 1,085
Anti-inflammatory effects of Rhodiola rosea L.: A review
Pu, W.-L., Zhang, M.-Y., Bai, R.-Y., Sun, L.-K., Li, W.-H., Yu, Y.-L., Zhang, Y., Song, L., Wang, Z.-X., Peng, Y.-F., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109552 · Cited by 227
Wang, D.-S., Luo, H.-Y., Qiu, M.-Z., Wang, Z.-Q., Zhang, D.-S., Wang, F.-H., Li, Y.-H., & Xu, R.-H. (2012) · Medical Oncology · doi:10.1007/s12032-012-0226-8 · Cited by 224
Degradable Semiconducting Oligomer Amphiphile for Ratiometric Photoacoustic Imaging of Hypochlorite
Yin, C., Zhen, X., Fan, Q., Huang, W., & Pu, K. (2017) · ACS Nano · doi:10.1021/acsnano.7b01092 · Cited by 227
Marshall, J. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-207-6_8 · Cited by 217
Gu, X.-B., Tian, T., Tian, X.-J., & Zhang, X.-J. (2015) · Scientific Reports · doi:10.1038/srep12493 · Cited by 178
Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer
Kawada, M., Seno, H., Kanda, K., Nakanishi, Y., Akitake, R., Komekado, H., Kawada, K., Sakai, Y., Mizoguchi, E., & Chiba, T. (2012) · Oncogene · doi:10.1038/onc.2011.498 · Cited by 219
“Recent studies indicated that tumor growth and dissemination are the result of dynamic interactions between cancer cells and stromal cells of the tumor microenvironment (Mantovani et al., 2008).”
Melatonin and Cancer Hallmarks
Talib, W. H. (2018) · Molecules · doi:10.3390/molecules23030518 · Cited by 216
“The link between chronic inflammation and cancer development was reported in previous studies [103,104].”
ResultNon-genetic engineering of cells for drug delivery and cell-based therapy
Wang, Q., Cheng, H., Peng, H., Zhou, H., Li, P. Y., & Langer, R. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.12.003 · Cited by 225
Inflammation in the context of oral cancer
Feller, L., Altini, M., & Lemmer, J. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.07.003 · Cited by 221
“motility, cancer cell invasion and metastasis [5,8,27–30].”
BackgroundInfluentialCCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
Svensson, S., Abrahamsson, A., Rodriguez, G. V., Olsson, A.-K., Jensen, L., Cao, Y., & Dabrosin, C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0204 · Cited by 221
“Macrophages constitute a major component of the stroma in breast cancer (1, 2), but the role of estrogens in macrophage migration and function in breast cancer has not previously been fully explored.”
BackgroundAdipokines: masterminds of metabolic inflammation
Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 192
The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis
Carmi, Y., Voronov, E., Dotan, S., Lahat, N., Rahat, M. A., Fogel, M., Huszar, M., White, M. R., Dinarello, C. A., & Apte, R. N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901511 · Cited by 224
Absenger, G., Szkandera, J., Pichler, M., Stotz, M., Arminger, F., Weissmueller, M., Schaberl-Moser, R., Samonigg, H., Stojakovic, T., & Gerger, A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.346 · Cited by 225
“predicts clinical outcome in stage II and”
Becht, E., Giraldo, N. A., Germain, C., de Reyniès, A., Laurent-Puig, P., Zucman-Rossi, J., Dieu-Nosjean, M.-C., Sautès-Fridman, C., & Fridman, W. H. (2016) · Advances in Immunology · doi:10.1016/bs.ai.2015.12.002 · Cited by 213
Tumor microenvironment responsive drug delivery systems
He, Q., Chen, J., Yan, J., Cai, S., Xiong, H., Liu, Y., Peng, D., Mo, M., & Liu, Z. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.08.003 · Cited by 219
Evaluation of the association of chronic inflammation and cancer: Insights and implications
Nigam, M., Mishra, A. P., Deb, V. K., Dimri, D. B., Tiwari, V., Bungau, S. G., Bungau, A. F., & Radu, A.-F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115015 · Cited by 205
Priem, B., van Leent, M. M. T., Teunissen, A. J. P., Sofias, A. M., Mourits, V. P., Willemsen, L., Klein, E. D., Oosterwijk, R. S., Meerwaldt, A. E., Munitz, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.059 · Cited by 222
“(H) Histograms of concatenated samples, per treatment group, showing F4/80 expression in CD11b + , Ly6C - , Ly6G - cells and quantification of F4/80 + TAMs per treatment group.”
BackgroundInfluentialMcDonald, B., Spicer, J., Giannais, B., Fallavollita, L., Brodt, P., & Ferri, L. E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24409 · Cited by 222
Mast cells have a protumorigenic role in human thyroid cancer
Melillo, R. M., Guarino, V, Avilla, E., Galdiero, M. R., Liotti, F., Prevete, N., Rossi, F. W., Basolo, F., Ugolini, C., de Paulis, A., et al. (2010) · Oncogene · doi:10.1038/onc.2010.348 · Cited by 219
Multiple changes in sialic acid biology during human evolution
Varki, A. (2009) · Glycoconjugate Journal · doi:10.1007/s10719-008-9183-z · Cited by 219
Warming the mouse to model human diseases
Ganeshan, K., & Chawla, A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.48 · Cited by 224
Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis
Chiodoni, C., Colombo, M. P., & Sangaletti, S. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9221-8 · Cited by 221
Cancer Cells in Transit: The Vascular Interactions of Tumor Cells
Konstantopoulos, K., & Thomas, S. N. (2009) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-061008-124949 · Cited by 215
“It is therefore possible that attenuation of leukocyte recruitment will improve the activity of current antiangiogenic and other antimetastatic therapies for patients with cancer (113).”
Neutrophils: important contributors to tumor progression and metastasis
Swierczak, A., Mouchemore, K. A., Hamilton, J. A., & Anderson, R. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9594-9 · Cited by 220
Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
La‐Beck, N. M., Jean, G. W., Huynh, C., Alzghari, S. K., & Lowe, D. B. (2015) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1643 · Cited by 216
Chemokines in cancer related inflammation
Allavena, P., Germano, G., Marchesi, F., & Mantovani, A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.013 · Cited by 215
“Chemokines and their receptors are major players of this cancer-related inflammation (CRI) [1–4].”
BackgroundSelf-citationJi, Z., He, L., Regev, A., & Struhl, K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821068116 · Cited by 219
“Tumor-associated inflammation results from both an intrinsic pathway, in which mutations in cancer cells activate inflammatory gene expression, and an extrinsic pathway, in which cytokines and chemokines secreted by tumor-associated immune cells create inflammatory microenvironments (3).”
BackgroundMedical application of glycosaminoglycans: a review
Köwitsch, A., Zhou, G., & Groth, T. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2398 · Cited by 209
“This likely originates from the association of inflammation and cancer (Mantovani et al., 2008).”
BackgroundThe diverse mechanisms and anticancer potential of naphthoquinones
Pereyra, C. E., Dantas, R. F., Ferreira, S. B., Gomes, L. P., & Silva-Jr, F. P. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0925-8 · Cited by 208
Simpson, K. D., Templeton, D. J., & Cross, J. V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201161 · Cited by 214
“T he inflammatory tumor microenvironment contributes to tumor growth and progression through a variety of mechanisms (1).”
BackgroundCai, Z., Sanchez, A., Shi, Z., Zhang, T., Liu, M., & Zhang, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1993 · Cited by 214
“Dynamic interaction between tumor and tumor microenvironment is essential for tumor growth, angiogenesis, and metastasis (43).”
BackgroundAdaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Wu, P., Gao, W., Su, M., Nice, E. C., Zhang, W., Lin, J., & Xie, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641469 · Cited by 209
Inflammation amplifier, a new paradigm in cancer biology
Atsumi, T., Singh, R., Sabharwal, L., Bando, H., Meng, J., Arima, Y., Yamada, M., Harada, M., Jiang, J.-J., Kamimura, D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2322 · Cited by 217
“Consistent with this notion, it has been reported that inflamed regions, as indicated by the accumulation of immune cells, are present from the very initial to final phases of tumordevelopment (1, 17).”
BackgroundInfluentialKeizman, D., Ish-Shalom, M., Huang, P., Eisenberger, M. A., Pili, R., Hammers, H., & Carducci, M. A. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.001 · Cited by 213
Jing, W., McAllister, D., Vonderhaar, E. P., Palen, K., Riese, M. J., Gershan, J., Johnson, B. D., & Dwinell, M. B. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0573-5 · Cited by 217
Ohno, Y., Nakashima, J., Ohori, M., Hatano, T., & Tachibana, M. (2010) · Journal of Urology · doi:10.1016/j.juro.2010.05.028 · Cited by 217
Liu, X., Sun, X., Liu, J., Kong, P., Chen, S., Zhan, Y., & Xu, D. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.06.006 · Cited by 212
“Discussion It is well known that the systemic inflammatory response plays an important role in carcinogenesis and tumor progression [23,24].”
BackgroundMonocytes and Macrophages in Cancer: Development and Functions
Richards, D. M., Hettinger, J., & Feuerer, M. (2013) · Cancer Microenvironment · doi:10.1007/s12307-012-0123-x · Cited by 210
Capparuccia, L., & Tamagnone, L. (2009) · Journal of Cell Science · doi:10.1242/jcs.030197 · Cited by 206
“Immune cells represent a double-edged sword during tumorigenesis (Mantovani et al., 2008).”
BackgroundInfluentialIs there a role for carbohydrate restriction in the treatment and prevention of cancer?
Klement, R. J., & Kämmerer, U. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-75 · Cited by 206
“Inflammation is a wellestablished driver of early tumorigenesis and accompanies most, if not all cancers [148].”
BackgroundBromelain’s activity and potential as an anti-cancer agent: Current evidence and perspectives
Chobotova, K., Vernallis, A. B., & Majid, F. A. A. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.08.001 · Cited by 209
“The leading viewpoint suggests that control of chronic inflammation could reduce the incidence of cancer as well as inhibit cancer progression [26].”
BackgroundNoh, H., Eomm, M., & Han, A. (2013) · Journal of Breast Cancer · doi:10.4048/jbc.2013.16.1.55 · Cited by 217
“It has been reported that tumors are linked with systemic inflammation [5,6].”
BackgroundThe metastatic niche and stromal progression
Sleeman, J. P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9373-9 · Cited by 203
The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy
Rufo, N., Garg, A. D., & Agostinis, P. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.07.002 · Cited by 207
“On the other hand, these chemokines and cytokines can also recruit and/or sustain immunosuppressive immune cells to further fuel production of protumorigenic factors in a feed-forward loop [23].”
BackgroundBreast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment
Laborda-Illanes, A., Sanchez-Alcoholado, L., Dominguez-Recio, M. E., Jimenez-Rodriguez, B., Lavado, R., Comino-Méndez, I., Alba, E., & Queipo-Ortuño, M. I. (2020) · Cancers · doi:10.3390/cancers12092465 · Cited by 206
“In this respect, the mechanism by which gut bacteria can promote BC is through chronic inflammation, which is associated with tumor development [66].”
BackgroundAngiogenesis in Wounds Treated by Microdeformational Wound Therapy
Erba, P., Ogawa, R., Ackermann, M., Adini, A., Miele, L. F., Dastouri, P., Helm, D., Mentzer, S. J., D’Amato, R. J., Murphy, G. F., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31820563a8 · Cited by 207
Carcinogenesis: Failure of resolution of inflammation?
Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107670 · Cited by 205
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer
Goc, J., Lv, M., Bessman, N. J., Flamar, A.-L., Sahota, S., Suzuki, H., Teng, F., Putzel, G. G., Eberl, G., Withers, D. R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.029 · Cited by 212
Senescent alveolar macrophages promote early-stage lung tumorigenesis
Prieto, L. I., Sturmlechner, I., Graves, S. I., Zhang, C., Goplen, N. P., Yi, E. S., Sun, J., Li, H., & Baker, D. J. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.05.006 · Cited by 212
Interleukins in glioblastoma pathophysiology: implications for therapy
Yeung, Y., McDonald, K., Grewal, T., & Munoz, L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12008 · Cited by 210
“Finally, the inflammatory microenvironment, which is known to be the driving force for the progression of incipient neoplasias into highly malignant tumours (Mantovani et al., 2008; Solinas et al., 2010), is also found at the GBM lesions.”
BackgroundThe interplay between macrophages and angiogenesis in development, tissue injury and regeneration
Nucera, S., Biziato, D., & De Palma, M. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103227sn · Cited by 207
“Such degree of histological heterogeneity is accompanied by a remarkable heterogeneity of macrophage phenotypes (Lewis and Pollard, 2006; Mantovani et al., 2008; Qian and Pollard, 2010; Squadrito and De Palma, 2011).”
BackgroundMicro RNA s play a central role in molecular dysfunctions linking inflammation with cancer
Tili, E., Michaille, J., & Croce, C. M. (2013) · Immunological Reviews · doi:10.1111/imr.12050 · Cited by 206
“This milieu stimulates cell migration, proliferation, survival, angiogenesis, and metastasis, and facilitates the subversion of adaptive immunity, thus favoring cancer progression (13, 14).”
BackgroundInfluentialCancer‐promoting tumor‐associated macrophages: New vistas and open questions
Mantovani, A., Germano, G., Marchesi, F., Locatelli, M., & Biswas, S. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201141894 · Cited by 207
Self-citationHan, S., Liu, Y., Li, Q., Li, Z., Hou, H., & Wu, A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1629-7 · Cited by 209
“T-lymphocytes play an important role in host defenses against tumors, as they inhibit the proliferation and invasion of tumor cells via the induction of cytotoxic cell death and cytokine production [30, 42].”
BackgroundBlame the signaling: Role of cAMP for the resolution of inflammation
Tavares, L. P., Negreiros-Lima, G. L., Lima, K. M., E Silva, P. M. R., Pinho, V., Teixeira, M. M., & Sousa, L. P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105030 · Cited by 205
Bindels, L. B., Neyrinck, A. M., Claus, S. P., Le Roy, C. I., Grangette, C., Pot, B., Martinez, I., Walter, J., Cani, P. D., & Delzenne, N. M. (2016) · The ISME Journal · doi:10.1038/ismej.2015.209 · Cited by 209
“Therefore, one could speculate that such immune modulation could foster cancer proliferation (Mantovani et al., 2008).”
Marchesi, F., Piemonti, L., Fedele, G., Destro, A., Roncalli, M., Albarello, L., Doglioni, C., Anselmo, A., Doni, A., Bianchi, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1810 · Cited by 202
Self-citationOur perception of the mast cell from Paul Ehrlich to now
Beaven, M. A. (2009) · European Journal of Immunology · doi:10.1002/eji.200838899 · Cited by 202
Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells
Tartey, S., & Takeuchi, O. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2016.1261318 · Cited by 209
“chronic inflammation is a major risk factor in cancer development [78].”
BackgroundThe Anti-Inflammatory Effects of Vitamin D in Tumorigenesis
Liu, W., Zhang, L., Xu, H.-J., Li, Y., Hu, C.-M., Yang, J.-Y., & Sun, M.-Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092736 · Cited by 199
Carcinoma‐associated fibroblasts: Non‐neoplastic tumour‐promoting mesenchymal cells
Polanska, U. M., & Orimo, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24347 · Cited by 208
“It is now a well-established concept that epithelial cellautonomous TGF-b signalling influences carcinoma cells in a cell context-dependent fashion during both early and late stages of tumourigenesis (Massague, 2012).”
BackgroundNew perspectives in cancer immunotherapy: targeting IL-6 cytokine family
Soler, M. F., Abaurrea, A., Azcoaga, P., Araujo, A. M., & Caffarel, M. M. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007530 · Cited by 191
Feng, Y., Santoriello, C., Mione, M., Hurlstone, A., & Martin, P. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000562 · Cited by 206
“However, when innate immunity goes awry, inflammation does not always resolve, and it is believed that chronic, ‘‘smouldering,’’ and often subclinical inflammation can be the root cause of many human pathologies, including cancer [13–16].”
BackgroundB cells and antibodies in the defense against Mycobacterium tuberculosis infection
Achkar, J. M., Chan, J., & Casadevall, A. (2015) · Immunological Reviews · doi:10.1111/imr.12276 · Cited by 200
“Indeed, evidence exists that M2 macrophages are conducive to microbial persistence (109) as well as tumor progression (110, 111).”
BackgroundResveratrol in the chemoprevention and treatment of hepatocellular carcinoma
Bishayee, A., Politis, T., & Darvesh, A. S. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.10.002 · Cited by 204
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells
Sarkar, S., Döring, A., Zemp, F. J., Silva, C., Lun, X., Wang, X., Kelly, J., Hader, W., Hamilton, M., Mercier, P., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3597 · Cited by 207
Laoui, D., Van Overmeire, E., De Baetselier, P., Van Ginderachter, J. A., & Raes, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00489 · Cited by 200
“Semin Immunopathol (2013) 35(5):585–600.”
Radiation, Inflammation, and Immune Responses in Cancer
Multhoff, G., & Radons, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00058 · Cited by 202
“The link between cancer and inflammation can be viewed as consisting of two pathways: an intrinsic and an extrinsic pathway (Mantovani et al., 2008).”
BackgroundThe immune network in pancreatic cancer development and progression
Wörmann, S. M., Diakopoulos, K. N., Lesina, M., & Algül, H. (2014) · Oncogene · doi:10.1038/onc.2013.257 · Cited by 205
Qian, B.-Z., Zhang, H., Li, J., He, T., Yeo, E.-J., Soong, D. Y. H., Carragher, N. O., Munro, A., Chang, A., Bresnick, A. R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141555 · Cited by 198
“There is now substantial evidence that inflammation plays a critical role in promoting tumorigenesis and in the subse quent progression of tumors to malignancy (Mantovani et al., 2008; Grivennikov et al., 2010; Coussens et al., 2013).”
BackgroundHedgehog signaling: modulation of cancer properies and tumor mircroenvironment
Hanna, A., & Shevde, L. A. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0509-3 · Cited by 205
“sponses [82, 83].”
Cancer Mortality Risks from Long-term Exposure to Ambient Fine Particle
Wong, C. M., Tsang, H., Lai, H. K., Thomas, G. N., Lam, K. B., Chan, K. P., Zheng, Q., Ayres, J. G., Lee, S. Y., Lam, T. H., et al. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0626 · Cited by 203
“Two main biologic mechanisms to explain PM-associated cancer mortality have been postulated: first, an effect of oxidative stress induced by PM on epithelial cells to produce reactive oxygen species that can damage DNA, proteins, and lipids (12); and second, an effect of inflammation induced directly or indirectly by…”
Zhang, H., Liu, H., Shen, Z., Lin, C., Wang, X., Qin, J., Qin, X., Xu, J., & Sun, Y. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002058 · Cited by 207
Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis
Maisonneuve, P., Amar, S., & Lowenfels, A. B. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx019 · Cited by 196
“Cancer, and more specifically, PC, is linked to chronic inflammatory states [72, 73].”
BackgroundInflammation-mediated promotion of invasion and metastasis
Solinas, G., Marchesi, F., Garlanda, C., Mantovani, A., & Allavena, P. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9227-2 · Cited by 200
“Chronic non-resolving inflammation is a risk factor for cancer development, a link already perceived in the 19th century [1, 2]. Moreover, also in tumors which are not epidemiologically linked to inflammation, an inflammatory component is an essential part of the malignant microenvironment [ 3 ].”
BackgroundSelf-citationLink between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)
FERNANDES, J. V., DE MEDEIROS FERNANDES, T. A. A., DE AZEVEDO, J. C. V., COBUCCI, R. N. O., DE CARVALHO, M. G. F., ANDRADE, V. S., & DE ARAÚJO, J. M. G. (2015) · Oncology Letters · doi:10.3892/ol.2015.2884 · Cited by 196
“Oncoproteins that are associated with cancer, including Ras, Myc and RET, can also cause inflammation via the activation of signaling mechanisms involved in the production of proinflammatory cytokines and chemokines (64).”
Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense
Basith, S., Manavalan, B., Yoo, T. H., Kim, S. G., & Choi, S. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0802-7 · Cited by 203
“However, increasing evidence suggests that a seventh feature, inflammation, should also be included in this list (Mantovani et al., 2008; Kim et al., 2009).”
BackgroundTumor cell behaviour modulation by mesenchymal stromal cells
Kucerova, L., Matuskova, M., Hlubinova, K., Altanerova, V., & Altaner, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-129 · Cited by 200
“High level of G-CSF, renowned for the promotion of survival of leukocytes and their recruitment to the tissues, was detected in tumor/AT-MSC cocultures and contributed to formation of proinflammatory microenvironment [43].”
BackgroundResultHedlund, M., Padler-Karavani, V., Varki, N. M., & Varki, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803943105 · Cited by 199
“Indeed, many cancers are associated with chronic inflammation (29, 32–34), and there is good evidence from others that chronic activation of innate immune cells can promote carcinogenesis (30, 32).”
BackgroundDeng, Q., He, B., Liu, X., Yue, J., Ying, H., Pan, Y., Sun, H., Chen, J., Wang, F., Gao, T., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0409-0 · Cited by 204
“Tumor-associated macrophages derived from circulating monocytes are selectively released to tumor microenvironment by locally surged chemokines [4].”
BackgroundPET Imaging of Inflammation Biomarkers
Wu, C., Li, F., Niu, G., & Chen, X. (2013) · Theranostics · doi:10.7150/thno.6592 · Cited by 200
Baginska, J., Viry, E., Paggetti, J., Medves, S., Berchem, G., Moussay, E., & Janji, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00490 · Cited by 198
“Indeed, through their ability to produce cytokines such as tumor necrosis factor (TNF)-α and stromal cell-derived factor 1 (SDF-1), hypoxic tumor cells induce the homing of bone marrow-derived CD45+ myeloid cells to tumor areas (24).”
BackgroundXiang, T., Long, H., He, L., Han, X., Lin, K., Liang, Z., Zhuo, W., Xie, R., & Zhu, B. (2015) · Oncogene · doi:10.1038/onc.2013.537 · Cited by 194
Tumor Suppression and Promotion by Autophagy
Ávalos, Y., Canales, J., Bravo-Sagua, R., Criollo, A., Lavandero, S., & Quest, A. F. G. (2014) · BioMed Research International · doi:10.1155/2014/603980 · Cited by 196
“In this context, it is important to note that both inflammatory cells and cytokines are extremely relevant because a proinflammatory environment promotes proliferation and survival of malignant cells, stimulates angiogenesis, metastasis, and modifies the response to drugs [91].”
TLRs: Linking inflammation and breast cancer
Bhatelia, K., Singh, K., & Singh, R. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.035 · Cited by 188
Danese, S., & Mantovani, A. (2010) · Oncogene · doi:10.1038/onc.2010.109 · Cited by 199
“It also controls the expression of inflammatory cytokines, adhesion molecules, enzymes in the prostaglandin synthesis pathway (including COX-2), inducible nitric oxide synthase and a number of antiapoptotic genes, including Bcl-2, thus providing a survival advantage to tumor cells (Mantovani et al., 2008).”
BackgroundInfluentialSelf-citationHe, J., Shen, G., Ren, Z., Qin, H., Cui, C., Zhang, Y., Zeng, Y., & Jia, W. (2012) · Head & Neck · doi:10.1002/hed.22008 · Cited by 201
“It is a consensus that the adaptive immune system carries out immune surveillance and can eliminate newborn tumors, but effective adaptive immune responses are always suppressed in established tumors through several pathways, including inhibition of dendritic cell differentiation and activation, infiltration of regula…”
BackgroundTargeting CAFs to overcome anticancer therapeutic resistance
Saw, P. E., Chen, J., & Song, E. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2022.03.001 · Cited by 197
Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials
Zhang, W., Wang, M., Ji, C., Liu, X., Gu, B., & Dong, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116930 · Cited by 178
Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin
Zhang, L., & Wang, H. (2015) · Marine Drugs · doi:10.3390/md13074310 · Cited by 202
“Abundant evidence supports the preposition that various cancers are triggered by inflammatory disease [44–46] and anti-inflammatory drugs such as aspirin or cyclooxygenase-2 (COX-2) inhibitors could reduce tumor recurrence [47,48].”
BackgroundInflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link
Conroy, H., Mawhinney, L., & Donnelly, S. C. (2010) · QJM · doi:10.1093/qjmed/hcq148 · Cited by 205
“Mounting evidence suggests that inflammation is closely associated with many types of cancer.(21) Inflammatory pathways designed to defend against infection and injury can promote an environment which favours tumour growth and metastasis.”
BackgroundCrosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression
Strouch, M. J., Cheon, E. C., Salabat, M. R., Krantz, S. B., Gounaris, E., Melstrom, L. G., Dangi-Garimella, S., Wang, E., Munshi, H. G., Khazaie, K., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1230 · Cited by 199
“Nevertheless, inflammatory cells are increasingly recognized to play a key role in the tumor microenvironment in many human cancers (25).”
Song, Z., Mao, D., Sung, S. H. P., Kwok, R. T. K., Lam, J. W. Y., Kong, D., Ding, D., & Tang, B. Z. (2016) · Advanced Materials · doi:10.1002/adma.201601214 · Cited by 202
Libby, P., & Kobold, S. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz058 · Cited by 197
“The recruitment of leucocytes to tumours and to plaques share considerable commonality (Figure 1).(27,28) Adhesion molecules for leucocytes contribute in both cases and the locomotion of adherent cells into the lesions depends on the action of chemokines.”
Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
Sammarco, G., Varricchi, G., Ferraro, V., Ammendola, M., De Fazio, M., Altomare, D. F., Luposella, M., Maltese, L., Currò, G., Marone, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092106 · Cited by 198
Myeloid suppressor cells in cancer and autoimmunity
Sica, A., & Massarotti, M. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.010 · Cited by 201
Self-citationAngiotensin II Drives the Production of Tumor-Promoting Macrophages
Cortez-Retamozo, V., Etzrodt, M., Newton, A., Ryan, R., Pucci, F., Sio, S. W., Kuswanto, W., Rauch, P. J., Chudnovskiy, A., Iwamoto, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.015 · Cited by 199
“…tumor progression by promoting inflammation, stimulating angiogenesis, enhancing tumor cell migration and metastasis, and suppressing anti-tumor immunity (De Palma et al., 2007; Mantovani et al., 2008; Grivennikov et al., 2010; Qian and Pollard, 2010; Hanahan and Coussens, 2012).”
Pang, L. Y., Hurst, E. A., & Argyle, D. J. (2016) · Stem Cells International · doi:10.1155/2016/2048731 · Cited by 192
“Importantly, inflammatory cells and the cellular mediators of inflammation are prominent constituents of the microenvironment of all tumours [21].”
Molecular and histopathology directed therapy for advanced bladder cancer
Alifrangis, C., McGovern, U., Freeman, A., Powles, T., & Linch, M. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0208-0 · Cited by 199
Clinical characteristics and outcomes of cancer patients with COVID‐19
Yang, F., Shi, S., Zhu, J., Shi, J., Dai, K., & Chen, X. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25972 · Cited by 198
“The link between inflammation and cancer is well documented, chronic inflammation may promote the occurrence and development of cancer.(21) Some cancer biomarkers slightly increase in the inflammatory state.”
Background
Metadata
- Authors
- Mantovani, A., Allavena, P., Sica, A., & Balkwill, F.
- Affiliations
- IRCCS Humanitas Research Hospital (IT)
- Fondazione Humanitas per la Ricerca (IT)
- Queen Mary University of London (GB)
- Venue
- Nature
- Published
- 2008-07-01
- Volume
- 454
- Issue
- 7203
- Pages
- 436-444
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2123105952
- Semantic Scholar
- b3a9e344a32ad6ca402d9149ac74b2b1df9e3076
- Cited by
- 11,399
- References
- 175
- Citations by year
- 2026: 419 · 2025: 554 · 2024: 655 · 2023: 761 · 2022: 848 · 2021: 878 · 2020: 864 · 2019: 759 · 2018: 752 · 2017: 732 · 2016: 692 · 2015: 683 · 2014: 643 · 2013: 574 · 2012: 510
- FWCI
- 26.32
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- tumor inflammation, tumor microenvironment, inflammatory mediators, angiogenesis, metastasis, immune evasion, chemoresistance, endocrine response, inflammatory signaling, therapeutic target
- MeSH terms
- Humans, Inflammation, Leukocytes, Neoplasm Invasiveness, Neoplasms, Oncogenes, Gonadal Steroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.